13,534
Total Claims
$1.5M
Drug Cost
1,145
Beneficiaries
$1,277
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-16%
Cost per patient vs peers
$1,277 vs $1,524 avg
-17%
Brand preference vs peers
11.3% vs 13.7% avg
Brand vs Generic
89% generic
Brand: 1,530 claims · $1.2M
Generic: 12,004 claims · $280K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 753 | $626K |
| Rivaroxaban | 321 | $305K |
| Ticagrelor | 152 | $102K |
| Evolocumab | 30 | $41K |
| Ranolazine | 257 | $35K |
| Alirocumab | 42 | $30K |
| Sacubitril/Valsartan | 24 | $25K |
| Valsartan | 455 | $22K |
| Metoprolol Succinate | 967 | $16K |
| Digoxin | 532 | $14K |
| Flecainide Acetate | 184 | $12K |
| Clopidogrel Bisulfate | 645 | $10K |
| Atorvastatin Calcium | 744 | $9,794 |
| Isosorbide Mononitrate | 399 | $8,946 |
| Carvedilol | 895 | $8,307 |
Prescribing Profile
79
Unique Drugs
$957K
Patient Profile
77
Avg Age
51%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About